World High Life (OTCQB: WRHLF) acquired its wholly owned subsidiary, Love Hemp, less than a year ago, and since securing the London-based CBD company, World High Life continues to have that decision validated. In 2020, Love Hemp has enjoyed a breakout year of consistently strong growth, and the company recently announced that it has once again posted impressive numbers, this time for July 2020.
After reporting record financials in the first two quarters of 2020 that led to a 107% increase in online sales from January to May 2020, Love Hemp has continued that success to start the third quarter. In July, the company reported a 57% growth in sales over corporate sales in June 2020. Additionally, Love Hemp said its online sales remain significantly higher than pre-COVID-19 levels, which made up 62% of all of the company’s sales in July compared to the 40% of sales registered in January 2020.
Love Hemp is spearheading the development of the United Kingdom’s (UK) leading range of trusted CBD products, and its Chief Executive Officer (CEO), Tony Calamita, said of the continued growth, “The wellness industry isn’t showing any signs of slowing down. What we have witnessed is an increased consumption of CBD during the pandemic, and we expect this to continue post-COVID-19.”
In fact, the growth has been so strong this year that Love Hemp has not only produced impressive sales results month after month, but it is now expanding its operations to meet overwhelming consumer demand. World High Life’s subsidiary has started construction on a new multi-level 13,500-square-foot facility that will increase production by more than five times its current output across its entire range of CBD products, including oils, cosmetics, and capsules.
The company announced that the new facility, which should be completed in about six months, will increase its daily on-site production from a limit of about 8,000 units of CBD oils, cosmetics, and capsules currently, to in excess of, 43,000 units per day when the project is completed in early 2021.
Love Hemp’s CEO commenting on the expansion said, “This expansion further increases our capabilities in striving to exceed customer and consumer requirements while improving storage and production capabilities, lead times and ensuring the safety of our staff. Our strategy is to continue to expand our local footprint, contributing to the future growth of our business, while also providing quality CBD products to our consumers throughout the UK and around the world.”
Expanding operations to increase production output comes at just the right time as the company’s sales continue to explode and as Love Hemp launched two new brands into the market this year. Love Hemp has over 80 products, including oils, sprays, edibles, cosmetics, and vapes, and the company currently enjoys around 1,200 retail listings. Calamita has always pointed to new product development, which is at the heart of everything the company does, to stay on top of what consumers are demanding more of from Love Hemp and the industry in general. “We currently have 15 new products in the development stage, and we remain committed to creating the UK’s leading range of trusted CBD products.”
In April, Love Hemp launched Love Hemp Immune, a blend of CBD, essential vitamins, including vitamins C and D, and bilberry extract to maintain a healthy immune system by supporting our body’s natural defenses. And, then in July, World High Life announced Love Hemp’s new brand, “Buzz Leaf.”
The Buzz Leaf product line is aimed at younger consumers that include the release of four broad spectrum CBD infused e-liquids with added terpenes, and eventually the launch of a full range of CBD products, including CBD oils and capsules. According to the company, the e-liquids feature exotic flavors that contain 500mg of CBD.
Love Hemp is enjoying incredible demand this year, and it’s that demand that has the company staying proactive by adding new brands for consumers to enjoy, by expanding its operations to produce even more products, and by redesigning its global online retailer, https://www.cbdoilsuk.com, a premium CBD oil and cannabidiol supplier in the UK, to handle current and new customers that are finding their way to a company that has proven it understands the moment and intends to continue adding to what is already an incredible 2020.
To learn more about Love Hemp visit: https://www.love-hemp.com
To learn more about the new Buzz Leaf product line visit: https://www.cbdoilsuk.com
For direct questions, call their toll-free number in North America: 1-888-616-9745
About World High Life
World High Life PLC is an investment company with a strategic focus to invest in and/or acquire companies operating in the CBD wellness and medicinal cannabis industry. The Company’s wholly owned subsidiary, Love Hemp Ltd., is one of the UK’s leading CBD and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes, and a variety of edible and water-based CBD products. Love Hemp has established relationships with over 1,200 stores in the UK, including leading brands such as Ocado, Holland & Barrett, and WH Smith.
About Stock Market Media Group
Stock Market Media Group is a news & media content development IR firm offering a platform for corporate stories to unfold in the media with press releases, research reports, corporate videos, radio-style CEO interviews, and feature news articles.
This article was written based on publicly available information. Stock Market Media Group may, from time to time, include our own opinions about the companies, their business, markets, and opportunities in our articles. Any opinions we may offer about any of the companies we write about are solely our own and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions you may make concerning any of the securities we write about are solely your responsibility based on your own due diligence. Our publications are provided only as an informational aid, and as a starting point for doing additional independent research. We encourage you to invest carefully and read the investor information available at the web site of the U.S. Securities and Exchange Commission at www.sec.gov, where you can also find all of World High Life’s filings and disclosures. We also recommend, as a general rule, that before investing in any securities, you consult with a professional financial planner or advisor, and you should conduct a complete and independent investigation before investing in any security after prudent consideration of all pertinent risks. We are not a registered broker, dealer, analyst, or advisor. We hold no investment licenses and may not sell, offer to sell, or offer to buy any security. Our publications about World High Life are not a recommendation to buy or sell a security.
Should Stock Market Media Group and its management own shares in the profiled company, they may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the company’s profile. Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment. Under the Securities Act of 1933, Section 17(b), Stock Market Media Group discloses that it was remunerated one-thousand, two hundred dollars paid for by a third party via bank wire, to produce this content related to World High Life.
Stock Market Media Group and its management do not own any shares in World High Life and never accepts compensation in free-trading shares for its marketing services of the company being profiled, however third parties that have compensated Stock Market Media Group may hold free-trading shares of the company being profiled and could very well be selling, holding or buying shares of the company’s stock at the same time the content is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
If Stock Market Media Group ever accepts compensation in the form of free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the company’s profile, our disclaimer will be updated accordingly to reflect the current position of any free trading shares received as compensation for our services.
For more information: www.stockmarketmediagroup.com.
News Provided by GlobeNewswire via QuoteMedia
Love Hemp Group PLC
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.